Operator Good day and Welcome to the BioCryst third-quarter 2024 earnings call. [Operator instructions] Please note this ...

Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) have earned a consensus recommendation of “Moderate ...

Begin your TipRanks Premium journey today. BioCryst (BCRX) Company Description: BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel small molecule drugs that block key enzymes ...

BioCryst Pharmaceuticals ( (BCRX) ) has released its Q3 earnings. Here is a breakdown of the information BioCryst Pharmaceuticals presented to ...

A Durham company says its drug is pacing for over $400 million in revenue this year. The goal is $1 billion.

Several analysts have issued reports on BCRX shares. JMP Securities raised their price target on shares of BioCryst Pharmaceuticals from $15.00 to $16.00 and gave the stock a “market outperform ...

(BCRX) on Monday reported a loss of $14 million in its third quarter. The Durham, North Carolina-based company said it had a ...

Good day and Welcome to the BioCryst Third Quarter 2024 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded. I would now ...

DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Monday reported a loss of $14 million in its third quarter. The Durham, North Carolina-based company said it had ...